开设账户
模拟账户
关于我们
即时报价及新闻
市场分析
财经日历
每日市场分析
交易平台
下载及介绍
使用教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
繁
简
EN
客户登入
开设账户
模拟账户
繁
简
EN
客户登入
开设账户
模拟账户
关于我们
上志国际介绍
上志国际优势
即时报价及新闻
即时报价
即时新闻
市场分析
财经日历
市场分析
交易平台
平台特点
平台教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
关于我们
交易细则
贵金属市场
交易平台
市场分析
推广和资讯
常见问题
联络我们
繁
简
EN
Brent crude up 5.00% at $75.67/bbl; WTI up 5.00% above $72.00/bbl. Spot gold down 1.54%, trading below $4,100/oz.
2026-07-08
Brent crude up 5.00% at $75.67/bbl; WTI up 5.00% above $72.00/bbl. Spot gold down 1.54%, trading below $4,100/oz.
返回
其他消息
2026-07-07
PBOC's Pan said on July 7 at the Hong Kong Fixed Income and Currency Summit and Bond Connect forum that China's foreign-exchange reserves will continue to increase their allocation to assets in Hong Kong, injecting momentum into Hong Kong capital markets. He said the reserves have been conducting asset allocation and investment trading in Hong Kong for more than a year.
PBOC's Pan said on July 7 at the Hong Kong Fixed Income and Currency Summit and Bond Connect forum that China's foreign-exchange reserves will continue to increase their allocation to assets in Hong Kong, injecting momentum into Hong Kong capital markets. He said the reserves have been conducting asset allocation and investment trading in Hong Kong for more than a year.
2026-07-07
July 7 — Naohu Technology’s implantable brain–computer interface (BCI) hand motor-function compensation system, described as fully implanted, fully wireless and full-function, began a GCP registration clinical trial at Fudan University‑affiliated Huashan Hospital. The multicenter GCP trial will be run with 15 tertiary hospitals in Shanghai and other regions to evaluate safety and efficacy for compensating upper‑limb function in patients with tetraplegia from cervical spinal cord injury. The devi
July 7 — Naohu Technology’s implantable brain–computer interface (BCI) hand motor-function compensation system, described as fully implanted, fully wireless and full-function, began a GCP registration clinical trial at Fudan University‑affiliated Huashan Hospital. The multicenter GCP trial will be run with 15 tertiary hospitals in Shanghai and other regions to evaluate safety and efficacy for compensating upper‑limb function in patients with tetraplegia from cervical spinal cord injury. The device is the first subdural cortical‑surface implantable BCI to enter China’s national Class III medical device registration clinical stage, marking a key step toward scaled clinical application of BCI technology in China.
Chat with us
, powered by
LiveChat